Linearmycin B

CAS: 182291-65-2

Ref. 3D-HHA29165

Produktinformation

• Name: Linearmycin B

Beschreibung

Linearmycin B is an analog of tolvaptan that has been shown to have potent anticancer activity. It works as an inhibitor of kinases, which are enzymes that play a crucial role in the growth and survival of cancer cells. Linearmycin B has been found to induce apoptosis in human cancer cell lines, making it a promising candidate for the development of new anticancer drugs. In addition, Linearmycin B has been shown to be effective in inhibiting tumor growth in vivo. This compound may also have potential therapeutic applications beyond cancer treatment, as it has been shown to be a potent inhibitor of urine kinases and Chinese hamster ovary cell protein kinases. Overall, Linearmycin B represents a promising avenue for the development of novel kinase inhibitors with potential therapeutic applications in various diseases.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 1,166.5 g/mol
• Formel: C₆₆H₁₀₃NO₁₆
• Reinheit: Min. 95%